Caricamento...
S1P signaling: new therapies and opportunities
Development of sphingosine-1-phosphate receptor 1 (S1P(1)) modulators to dampen inflammation and its sequelae is becoming increasingly promising for treating medical conditions characterized by significant immunopathology. As shown by the non-selective S1P receptor modulator FTY720 (fingolimod [Gile...
Salvato in:
| Pubblicato in: | F1000Prime Rep |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Faculty of 1000 Ltd
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4251414/ https://ncbi.nlm.nih.gov/pubmed/25580263 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12703/P6-109 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|